Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer

Cancer Letters

Volumn 199, Issue 1, 2003, Pages 91-98

  Iwasa, Satoshi ^a   Jin, Xin ^a,b   Okada, Kyoko ^a,b   Mitsumata, Masako ^a   Ooi, Akishi ^b  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Cancer tissue; Extracellular matrix; Immunohistochemistry; Metastasis; Seprase

Indexed keywords

SEPRASE; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER TISSUE; CARCINOGENESIS; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; TISSUE DISTRIBUTION; TISSUE SECTION;

EID: 0041878847     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(03)00315-X     Document Type: Article

References (39)

1. Liotta L.A., Tryggvason K., Garbisa S., Hart I., Foltz C.M., Shafie S. Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. 284:1980;67-68.
2. Nakajima M., Welch D.R., Belloni P.N., Nicolson G.L. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res. 47:1987;4869-4876.
3. Bernhard E.J., Muschel R.J., Hughes E.N. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res. 50:1990;3872-3877.
4. Baker E.A., Leaper D.J. Measuring gelatinase activity in colorectal cancer. Eur. J. Surg. Oncol. 28:2002;24-29.
5. Matsuyama Y., Takao S., Aikou T. Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas. J. Surg. Oncol. 80:2002;105-110.
6. Papadopoulou S., Scorilas A., Arnogianaki N., Papapanayiotou B., Tzimogiani A., Agnantis N., Talieri M. Expression of gelatinase-A (MMP-2) in human colon cancer and normal colon mucosa. Tumor Biol. 22:2001;383-389.
7. Rasmussen H.S., McCann P.P. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on Batimastat and Marimastat. Pharmacol. Ther. 75:1997;69-75.
8. Maekawa R., Maki H., Yoshida H., Hojo K., Tanaka H., Wada T., Uchida N., Takeda Y., Kasai H., Okamoto H., Tsuzuki H., Kambayashi Y., Watanabe F., Kawada K., Toda K., Ohtani M., Sugita K., Yoshioka T. Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res. 59:1999;1231-1235.
9. Iwasaki M., Nishikawa A., Fujimoto T., Akutagawa N., Manase K., Endo T., Yoshida K., Maekawa R., Yoshioka T., Kudo R. Anti-invasive effect of MMI-166, a new selective matrix metalloprotenease inhibitor, in cervical carcinoma cell lines. Gynecol. Oncol. 85:2002;103-107.
10. Oba K., Konno H., Tanaka T., Baba M., Kamiya K., Ohta M., Kaneko T., Shouji T., Igarashi A., Nakamura S. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166. Cancer Lett. 175:2002;45-51.
11. Heppner K.J., Matrisian L.M., Jensen R.A., Rodgers W.H. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am. J. Pathol. 149:1996;273-282.
12. Okada A., Bellocq J.P., Rouyer N., Chenard M.P., Rio M.C., Chambon P., Passet P. Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. Proc. Natl Acad. Sci. USA. 92:1995;2730-2734.
13. Pyke C., Kristensen P., Ralfkiaer E., Grondahl-Hansen J., Eriksen J., Blasi F., Dano K. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Am. J. Pathol. 138:1991;1059-1067.
14. Itoh T., Tanioka M., Yoshida H., Yoshioka T., Nishimoto H., Itohara S. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58:1998;1048-1051.
15. Itoh T., Tanioka M., Matsuda H., Nishimoto H., Yoshioka T., Suzuki R., Uehira M. Experimental metastasis is suppressed in MMP-9 deficient mice. Clin. Exp. Metastasis. 17:(2):1999;177-181.
16. Aoyama A., Chen W.T. A 170-kDa membrane-bound protease is associated with the expression of invasiveness by human malignant melanoma cells. Proc. Natl Acad. Sci. USA. 87:1990;8296-8300.
17. Monsky W.L., Lin C.Y., Aoyama A., Kelly T., Akiyama S.K., Mueller S.C., Chen W.T. A potential marker protease of invasiveness, seprase, is localized on invadopodia of human malignant melanoma cells. Cancer Res. 54:1994;5702-5710.
18. Artym V.V., Kindzelskii A.L., Chen W.T., Petty H.R. Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes; dependence on beta1 integrins and the cytoskeleton. Carcinogenesis. 23:2002;1593-1601.
19. Buo L., Meling G.I., Karlsrud T.S., Johansen H.T., Aasen A.O. Antigen levels of urokinase plasminogen activator and its receptor at the tumor-host interface of colorectal adenocarcinomas are related to tumor aggressiveness. Human Pathol. 26:1995;1133-1138.
20. J.L. Yang, D. Seetoo, Y. Wang, M. Ranson, C.R. Berney, J.M. Ham, P.J. Russell, P.J. Crowe, Urokinase-type plasminogen activator and its receptor in colorectal cancer: independent prognostic factors of metastasis and cancer-specific survival and potential therapeutic targets. Int. J. Cancer 89 (2000) 431-439.
21. Sato T., Nishimura G., Yonemura Y., Nojima N., Ninomiya I., Fujimura T., Sugiyama K., Miwa K., Miyazaki I., Nonomura A., Yamaguchi Y. Association of immunohistochemical detection of urokinase-type plasminogen activator with metastasis and prognosis in colorectal cancer. Oncology. 52:1995;347-352.
22. Kelly T., Kechelava S., Rozypal T.L., West K.W., Korourian S. Seprase, a membrane-bound protease, is overexpressed by invasive ductal carcinoma cells of human breast cancers. Mod. Pathol. 11:1998;855-863.
23. Ariga N., Sato E., Ohuchi N., Nagura H., Ohtani H. Stromal expression of fibroblast activation protein/seprase, a cell membrane serine proteinase and gelatinase is associated with longer survival in patients with invasive ductal carcinoma of breast. Int. J. Cancer. 95:2001;67-72.
24. Sawhney N., Garrahan N., Douglas-Jones A.G., Williams E.D. Epithelial-stromal interactions in tumors. A morphologic study of fibroepithelial tumors of the breast. Cancer. 70:1992;2115-2120.
25. Goldstein L.A., Ghersi G., Pineiro-Sanchez M.L., Salamone M., Yeh Y., Flessate D., Chen W.T. Molecular cloning of seprase; a serine integral membane proteinase from human melanoma. Biochem. Biophys. Acta. 1361:1997;11-19.
26. Scanlan M.J., Raj B.K., Calvo B., Garin-Chesa P., Sanz-Moncasi M.P., Healey J.H., Old L.J., Rettig W.J. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc. Natl Acad. Sci. USA. 91:1994;5657-5661.
27. Ito A., Nakajima S., Sasaguri Y., Nagase H., Mori Y. Co-culture of human breast adenocarcinoma MCF-7 cells and human dermal fibroblasts enhances the production of matrix metalloproteases 1,2 and 3 in fibroblasts. Br. J. Cancer. 71:1995;1039-1045.
28. Wang T.N., Albo D., Tuszynski G.P. Fibroblasts promote breast cancer cell invasion by upregulating tumor matrix metalloproteinase-9 production. Surgery. 132:2002;220-225.
29. Singer C.F., Kronstein N., Marton E., Kubista M., Cullen K.J., Hirtenlehner K., Seifert M., Kubista E. MMP-2 and MMP-9 expression in breast cancer-derived human fibroblasts is differentially regulated by stromal-epithelial interactions. Breast Cancer Res. Treat. 72:2002;69-77.
30. Himelstein B.P., Ganete-Soler R., Bernhard E.J., Muschael R.J. Induction of fibroblast 92 kDa gelatinase/type IV collagenase expression by direct contact with metastatic tumor cells. J. Cell Sci. 107:1994;477-486.
31. Noel A., Hajitou A., l'Hoir C., Maquoi E., Baramova E., Lewalle J.M., Ramacle A., Kebers F., Brown P., Calberg-Bacq C.M., Foidart J.M. Inhibition of stromal matrix metalloproteases: effects on breast tumor promotion by fibroblasts. Int. J. Cancer. 76:1998;267-273.
32. Lengyel E., Gum R., Juarez J., Clayman G., Seiki M., Sato H., Boyd D. Induction of Mr 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res. 55:1995;963-967.
33. Saad S., Bendall L.J., James A., Gottlieb D.J., Bradstock K.F. Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts. Breast Cancer Res. Treat. 63:2000;105-115.
34. Himelstein B.P., Muschel R.J. Induction of matrix metalloproteinase 9 expression in breast carcinoma cells by a soluble factor from fibroblasts. Clin. Exp. Metastasis. 14:1996;197-208.
35. Gohji K., Nakajima M., Fabra A., Bucana C.D., von Eschenbach A.C., Tsuruo T., Fidler I.J. Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn. J. Cancer Res. 85:1994;152-160.
36. Harvey S.R., Sait S.N.J., Xu Y., Bailey J.L., Penetrante R.M., Markus G. Demonstration of urokinase expression in cancer cells of colon adenocarcinomas by immunohistochemistry and in situ hybridization. Am. J. Pathol. 155:1999;1115-1120.
37. Okada K., Jin X., Iwasa S., Mitsumata M., Ooi A. Seprase, a membrane-type serine protease, has different expression patterns in intestinal- and diffuse-type gastric cancer. Oncology (Basel). 2003;. in press.
38. Mueller B.M., Yu Y.B., Laug W.E. Overexpression of plasminogen activator inhibitor 2 in human melanoma cells inhibits spontaneous metastasis in scid/ scid mice. Proc. Natl Acad. Sci. USA. 92:1995;205-209.
39. Kobayashi H., Gotoh J., Fujie M., Shinohara H., Moniwa N., Terao T. Inhibition of metastasis of Lewis lung carcinoma by a synthetic peptide within growth factor-like domain of urokinase in the experimental and spontaneous metastasis model. Int. J. Cancer. 57:1994;727-733.